Description
SK-GT-2 was established from a primary adenocarcinoma of gastric fundus from a 72-year-old Hispanic male previously treated for squamous cell carcinoma with radiation therapy and radical neck dissection. Pathology of recurrence demonstrated ulcerating poorly differentiated adenocarcinoma of the stomach invading spleen and epigastic fat with metastases to perisplenic and perigastric nodes. SK-GT-2 was found to be tumorigenic in athymic nu/nu mice. The Y chromosome could not be detected in this cell line by short tandem repeat-PCR analysis when tested at Glow Biologics. It cell line is a known phenomenon that due to the increased genetic instability of cancer cell lines the Y chromosome can be rearranged or lost resulting in lack of detection. The cell line is identical to the source provided by the depositor based on the STR-PCR analysis.
Adherent Suspension
Adherent
Suggested Medium
RPMI-1640 + 2mM Glutamine + 10% Foetal Bovine Serum (FBS)
Quality Control
SK-GT-2 Cell Line was tested and found to be free of mycoplasma, bacterial, viruses, and other toxins. All cells were above 95% viability before freezing.
Shippment
SK-GT-2 Cell Line will be shipped using dry ice.
Storage
Store the cell lines in liquid nitrogen vapor (less than -130°C)
Warranty
SK-GT-2 Cell Line is for research use only
